General Infectious Disease News Articles

Infectious Dis.

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Andriulli A et al. - In decompensated cirrhotic patients, anti-viral therapy with current regimens is feasible and associated with an overall SVR rate of 35.1%. Treatment ought to be pursued among patients who attain an EVR, and maintain a full course and dosage of therapy.


Today in GI Infectious Disease...keeping you current

Zinc and micronutrient combinations to combat gastrointestinal inflammation
Current Opinion in Clinical Nutrition & Metabolic Care, 10/23/09

The role of rifaximin in the treatment and chemoprophylaxis of travelers' diarrhea
Therapeutics and Clinical Risk Management, 10/21/09

Methane and the Gastrointestinal Tract
Digestive Diseases and Sciences, 10/22/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address